05/20/2024 4:20 PM | BioMarin Pharmaceutical (Issuer) Burkhart Erin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 4:16 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 2:57 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 9:11 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024 9:54 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024 4:58 PM | BioMarin Pharmaceutical (Issuer) Guyer Charles Greg (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/06/2024 3:40 PM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/06/2024 3:45 PM | BioMarin Pharmaceutical (Issuer) Davis George Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 4:37 PM | BioMarin Pharmaceutical (Subject) Davis George Eric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024 9:49 AM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2024 12:59 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024 3:07 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2024 3:11 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/15/2024 3:21 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/12/2024 2:07 PM | BioMarin Pharmaceutical (Issuer) Burkhart Erin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/12/2024 8:49 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024 8:54 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2024 3:24 PM | BioMarin Pharmaceutical (Filer)
| Form ARS | |
04/09/2024 3:07 PM | BioMarin Pharmaceutical (Filer)
| Form DEF 14A | |
04/09/2024 3:09 PM | BioMarin Pharmaceutical (Filer)
| Form DEFA14A | |
03/20/2024 4:13 PM | BioMarin Pharmaceutical (Issuer) Slamon Dennis (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:48 PM | BioMarin Pharmaceutical (Issuer) Mueller Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:50 PM | BioMarin Pharmaceutical (Issuer) Guyer Charles Greg (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:53 PM | BioMarin Pharmaceutical (Issuer) Davis George Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:55 PM | BioMarin Pharmaceutical (Issuer) Burkhart Erin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:36 PM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:40 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:42 PM | BioMarin Pharmaceutical (Issuer) Hardy Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:46 PM | BioMarin Pharmaceutical (Issuer) FUCHS HENRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 5:54 PM | BioMarin Pharmaceutical (Issuer) FUCHS HENRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 4:32 PM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 4:35 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 11:04 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 1:41 PM | BioMarin Pharmaceutical (Subject) FUCHS HENRY J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 11:04 AM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 4:10 PM | BioMarin Pharmaceutical (Issuer) FUCHS HENRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:12 PM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:14 PM | BioMarin Pharmaceutical (Issuer) Guyer Charles Greg (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:16 PM | BioMarin Pharmaceutical (Issuer) Davis George Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:18 PM | BioMarin Pharmaceutical (Issuer) Mueller Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:05 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold. |
02/27/2024 9:35 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 12:34 PM | BioMarin Pharmaceutical (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/13/2024 12:21 PM | BioMarin Pharmaceutical (Subject) DODGE & COX (Filed by)
| Form SC 13G/A | |
02/12/2024 4:20 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 2:24 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/09/2024 4:46 PM | BioMarin Pharmaceutical (Subject) Capital Research Global Investors (Filed by)
| Form SC 13G | |
02/09/2024 9:36 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024 8:46 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024 6:47 PM | BioMarin Pharmaceutical (Issuer) MEIER RICHARD A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 3:06 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/11/2024 1:40 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 9:09 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 10:48 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/28/2023 12:00 PM | BioMarin Pharmaceutical (Issuer) Countouriotis Athena (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/28/2023 12:03 PM | BioMarin Pharmaceutical (Issuer) Countouriotis Athena (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 12:11 PM | BioMarin Pharmaceutical (Issuer) Enyedy Mark J (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/28/2023 12:13 PM | BioMarin Pharmaceutical (Issuer) Enyedy Mark J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 12:15 PM | BioMarin Pharmaceutical (Issuer) Bodem Barbara W. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/28/2023 12:18 PM | BioMarin Pharmaceutical (Issuer) Bodem Barbara W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:14 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 8:57 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023 4:22 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/14/2023 5:18 PM | BioMarin Pharmaceutical (Issuer) Davis George Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 10:49 AM | BioMarin Pharmaceutical (Subject) Davis George Eric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 6:55 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:13 PM | BioMarin Pharmaceutical (Issuer) Hardy Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 1:53 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/17/2023 2:57 PM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2023 9:27 AM | Ajer Jeffrey Robert (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2023 12:59 PM | BioMarin Pharmaceutical (Issuer) FUCHS HENRY J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 12:35 PM | BioMarin Pharmaceutical (Subject) FUCHS HENRY J (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023 6:05 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2023 6:08 PM | BioMarin Pharmaceutical (Issuer) Davis George Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2023 12:30 PM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2023 9:39 AM | BIENAIME JEAN JACQUES (Reporting) BioMarin Pharmaceutical (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023 11:48 AM | BioMarin Pharmaceutical (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023 3:05 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/30/2023 10:35 AM | BioMarin Pharmaceutical (Issuer) Mueller Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:23 PM | Alles Mark J (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:24 PM | ANDERSON ELIZABETH M (Reporting) BioMarin Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:24 PM | BioMarin Pharmaceutical (Issuer) Dere Willard H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:25 PM | BioMarin Pharmaceutical (Issuer) HERON ELAINE J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:26 PM | BioMarin Pharmaceutical (Issuer) Ho Maykin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:26 PM | BioMarin Pharmaceutical (Issuer) HOMBACH ROBERT J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:27 PM | BioMarin Pharmaceutical (Issuer) LAWLIS V BRYAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:27 PM | BioMarin Pharmaceutical (Issuer) MEIER RICHARD A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:28 PM | BioMarin Pharmaceutical (Issuer) PYOTT DAVID E I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2023 5:29 PM | BioMarin Pharmaceutical (Issuer) Slamon Dennis (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |